I-Therapeutix, Inc. Announces Company Name Change
I-Therapeutix, Inc. announced today that it has changed its corporate name to Ocular Therapeutix, Inc. Amar Sawhney, President and CEO-stated
Pioneering Medical Innovations
I-Therapeutix, Inc. announced today that it has changed its corporate name to Ocular Therapeutix, Inc. Amar Sawhney, President and CEO-stated
Sometimes just getting FDA approval isn’t enough. AccessClosure got FDA clearance of its PMA vascular closure device, only to delay
I-Therapeutix, Inc. announced today that Mr. Richard Packard and Dr. Daniel Calladine from the Prince Charles Eye Unit, King Edward